BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

649 related articles for article (PubMed ID: 11494364)

  • 21. Msh2 acts in medium-spiny striatal neurons as an enhancer of CAG instability and mutant huntingtin phenotypes in Huntington's disease knock-in mice.
    Kovalenko M; Dragileva E; St Claire J; Gillis T; Guide JR; New J; Dong H; Kucherlapati R; Kucherlapati MH; Ehrlich ME; Lee JM; Wheeler VC
    PLoS One; 2012; 7(9):e44273. PubMed ID: 22970194
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Paradoxical delay in the onset of disease caused by super-long CAG repeat expansions in R6/2 mice.
    Morton AJ; Glynn D; Leavens W; Zheng Z; Faull RL; Skepper JN; Wight JM
    Neurobiol Dis; 2009 Mar; 33(3):331-41. PubMed ID: 19130884
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Loss of TDP-43 promotes somatic CAG repeat expansion in Huntington's disease knock-in mice.
    Bai D; Zhu L; Jia Q; Duan X; Chen L; Wang X; Hou J; Jiang G; Yang S; Li S; Li XJ; Yin P
    Prog Neurobiol; 2023 Aug; 227():102484. PubMed ID: 37315918
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Weight loss in Huntington disease increases with higher CAG repeat number.
    Aziz NA; van der Burg JM; Landwehrmeyer GB; Brundin P; Stijnen T; ; Roos RA
    Neurology; 2008 Nov; 71(19):1506-13. PubMed ID: 18981372
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A critical window of CAG repeat-length correlates with phenotype severity in the R6/2 mouse model of Huntington's disease.
    Cummings DM; Alaghband Y; Hickey MA; Joshi PR; Hong SC; Zhu C; Ando TK; André VM; Cepeda C; Watson JB; Levine MS
    J Neurophysiol; 2012 Jan; 107(2):677-91. PubMed ID: 22072510
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Patterns of CAG repeat instability in the central nervous system and periphery in Huntington's disease and in spinocerebellar ataxia type 1.
    Mouro Pinto R; Arning L; Giordano JV; Razghandi P; Andrew MA; Gillis T; Correia K; Mysore JS; Grote Urtubey DM; Parwez CR; von Hein SM; Clark HB; Nguyen HP; Förster E; Beller A; Jayadaev S; Keene CD; Bird TD; Lucente D; Vonsattel JP; Orr H; Saft C; Petrasch-Parwez E; Wheeler VC
    Hum Mol Genet; 2020 Aug; 29(15):2551-2567. PubMed ID: 32761094
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Modifiers of Somatic Repeat Instability in Mouse Models of Friedreich Ataxia and the Fragile X-Related Disorders: Implications for the Mechanism of Somatic Expansion in Huntington's Disease.
    Zhao X; Kumari D; Miller CJ; Kim GY; Hayward B; Vitalo AG; Pinto RM; Usdin K
    J Huntingtons Dis; 2021; 10(1):149-163. PubMed ID: 33579860
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Huntington's disease: clinical and molecular genetics].
    Warita H; Shiro Y; Kashihara K; Abe K
    Nihon Rinsho; 1999 Apr; 57(4):896-9. PubMed ID: 10222786
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Triplet repeat mutation length gains correlate with cell-type specific vulnerability in Huntington disease brain.
    Shelbourne PF; Keller-McGandy C; Bi WL; Yoon SR; Dubeau L; Veitch NJ; Vonsattel JP; Wexler NS; ; Arnheim N; Augood SJ
    Hum Mol Genet; 2007 May; 16(10):1133-42. PubMed ID: 17409200
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lack of huntingtin promotes neural stem cells differentiation into glial cells while neurons expressing huntingtin with expanded polyglutamine tracts undergo cell death.
    Conforti P; Camnasio S; Mutti C; Valenza M; Thompson M; Fossale E; Zeitlin S; MacDonald ME; Zuccato C; Cattaneo E
    Neurobiol Dis; 2013 Feb; 50():160-70. PubMed ID: 23089356
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gender of the embryo contributes to CAG instability in transgenic mice containing a Huntington's disease gene.
    Kovtun IV; Therneau TM; McMurray CT
    Hum Mol Genet; 2000 Nov; 9(18):2767-75. PubMed ID: 11063736
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transgenic mice harboring a full-length human mutant DRPLA gene exhibit age-dependent intergenerational and somatic instabilities of CAG repeats comparable with those in DRPLA patients.
    Sato T; Oyake M; Nakamura K; Nakao K; Fukusima Y; Onodera O; Igarashi S; Takano H; Kikugawa K; Ishida Y; Shimohata T; Koide R; Ikeuchi T; Tanaka H; Futamura N; Matsumura R; Takayanagi T; Tanaka F; Sobue G; Komure O; Takahashi M; Sano A; Ichikawa Y; Goto J; Kanazawa I
    Hum Mol Genet; 1999 Jan; 8(1):99-106. PubMed ID: 9887337
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Uninterrupted CAG repeat drives striatum-selective transcriptionopathy and nuclear pathogenesis in human Huntingtin BAC mice.
    Gu X; Richman J; Langfelder P; Wang N; Zhang S; Bañez-Coronel M; Wang HB; Yang L; Ramanathan L; Deng L; Park CS; Choi CR; Cantle JP; Gao F; Gray M; Coppola G; Bates GP; Ranum LPW; Horvath S; Colwell CS; Yang XW
    Neuron; 2022 Apr; 110(7):1173-1192.e7. PubMed ID: 35114102
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Methods for Assessing DNA Repair and Repeat Expansion in Huntington's Disease.
    Massey T; McAllister B; Jones L
    Methods Mol Biol; 2018; 1780():483-495. PubMed ID: 29856032
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Longitudinal behavioral, cross-sectional transcriptional and histopathological characterization of a knock-in mouse model of Huntington's disease with 140 CAG repeats.
    Rising AC; Xu J; Carlson A; Napoli VV; Denovan-Wright EM; Mandel RJ
    Exp Neurol; 2011 Apr; 228(2):173-82. PubMed ID: 21192926
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice.
    Mangiarini L; Sathasivam K; Seller M; Cozens B; Harper A; Hetherington C; Lawton M; Trottier Y; Lehrach H; Davies SW; Bates GP
    Cell; 1996 Nov; 87(3):493-506. PubMed ID: 8898202
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Amelioration of Huntington's disease phenotype in astrocytes derived from iPSC-derived neural progenitor cells of Huntington's disease monkeys.
    Cho IK; Yang B; Forest C; Qian L; Chan AWS
    PLoS One; 2019; 14(3):e0214156. PubMed ID: 30897183
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differential effects of the Huntington's disease CAG mutation in striatum and cerebellum are quantitative not qualitative.
    Fossale E; Seong IS; Coser KR; Shioda T; Kohane IS; Wheeler VC; Gusella JF; MacDonald ME; Lee JM
    Hum Mol Genet; 2011 Nov; 20(21):4258-67. PubMed ID: 21840924
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Continuous and periodic expansion of CAG repeats in Huntington's disease R6/1 mice.
    Møllersen L; Rowe AD; Larsen E; Rognes T; Klungland A
    PLoS Genet; 2010 Dec; 6(12):e1001242. PubMed ID: 21170307
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Time course of early motor and neuropathological anomalies in a knock-in mouse model of Huntington's disease with 140 CAG repeats.
    Menalled LB; Sison JD; Dragatsis I; Zeitlin S; Chesselet MF
    J Comp Neurol; 2003 Oct; 465(1):11-26. PubMed ID: 12926013
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 33.